MSACL 2018 EU Abstract

Self-Classified Topic Area(s): Tissue Imaging

Next Generation Sequencing After MALDI MSI – A Feasibility Study

Kristina Schwamborn, Christine Bollwein, Anne Jacob, Wilko Weichert, Nicole Pfarr
Institute of Pathology, TU Munich, Munich, Germany

Warning: Undefined variable $headshot in /var/www/html/view_abstract/view_abstract_in_program.php on line 704

Kristina Schwamborn (Presenter)
Institute of Pathology, TU Munich

Relevant Financial Disclosures (within past 24 months, reported on Aug 31, 2021)

Honorarium/Expenses Roche, MSD

Committee/Board/Advisory Board MSD

Discussing Products? NO, presenter will NOT present educational content related to products/services of the ineligible company(ies) listed above.

Conflict mitigation NOT REQUIRED.

Abstract

Limited amount of sample material is an inherent problem in early cancer diagnostics. Thus, developing strategies to enable multiple test to be performed on the same tissue section are needed. Combining MALDI MSI and next generation sequencing using only a single tissue section is feasible and could be of value in cases of limited sample material.